Canopy Growth's Medical Marijuana: A Potential Rebound Play
Investors are watching canopy growth's medical marijuana as a potential engine for a rebound. This guide breaks down ...
Assess which retirement index fund offers the best expense ratio, balancing cost with diversification and tracking accuracy.
28,154 articlesInvestors are watching canopy growth's medical marijuana as a potential engine for a rebound. This guide breaks down ...
A cross-chain breach targeting the Verus-Ethereum bridge drained more than $11 million, triggering renewed focus on s...
A biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
SpaceX is the talk of Wall Street, but a rush to buy at the IPO could be reckless. This guide explains why waiting fo...
Private SpaceX uses extended lockups for insiders, signaling a disciplined cash strategy. This article breaks down wh...
The dutch bros stock gained 23.8% last month, powering higher on a mix of macro relief and company-specific growth si...
Air-taxi darlings Joby, Archer, and EHang have fallen sharply in 2026 as cert timelines and cash burn loom large. Inv...
Industry chatter points to a late-2026 filing for a BlackRock XRP ETF, contingent on liquidity and demand. Six XRP ET...
Investors pulled back from spot XRP ETFs this week, registering zero net inflows across seven trading sessions. XRP p...
A sharp move in a gold royalty stock can trigger questions for both traders and long-term investors. This article bre...
Intel is resetting expectations around AI with a focus on edge infrastructure and domestic manufacturing, signaling a...
As Warren Buffett's successor, Greg Abel has begun steering Berkshire Hathaway's portfolio with careful turns. A nota...